# Pharma-Pen (Formerly Innoject) Auto-injectory TIV

> **NCT00335855** · PHASE1 · WITHDRAWN · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)**

## Conditions studied

- Influenza

## Interventions

- **DEVICE:** Auto-injector for IM/SC vaccine administration

## Key facts

- **NCT ID:** NCT00335855
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** —
- **Primary completion:** —
- **Final completion:** 2006-10
- **Target enrollment:** 0 (ACTUAL)
- **Last updated:** 2019-01-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00335855

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00335855, "Pharma-Pen (Formerly Innoject) Auto-injectory TIV". Retrieved via AI Analytics 2026-07-31 from https://api.ai-analytics.org/clinical/NCT00335855. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*